All Health articles – Page 30
-
BusinessChuck Norris versus gadolinium
US action star is suing 11 drug firms for $10m, claiming his wife was poisoned by gadolinium from her MRIs
-
BusinessNovartis to buy AAA for radioligand cancer drugs
$3.9bn deal follows European approval of Advanced Accelerator Applications’ first-in-class radionuclide drug Lutathera
-
BusinessLilly and CureVac to collaborate on mRNA cancer vaccines
Deal could see CureVac net up to $1.8 billion in upfront and milestone payments
-
ArticleSilicones – enabling the next big leap in prosthetics and health
Safe, reliable and versatile, silicones are changing lives
-
BusinessGSK’s shingles vaccine gets thumbs up in North America
Inoculation slated to be a blockbuster
-
OpinionNatural selection
Bioactive compounds don’t just inspire new synthetic strategies, they’re also the ultimate test
-
NewsNew guidelines to standardise toxicity testing for nanomaterials
OECD hopes methods will ensure companies are singing from same song sheet on nanosafety
-
BusinessJudges overturn J&J talc cancer claims
Two new rulings follow trend of reversing large jury-awarded damages as firm works through thousands of cases
-
OpinionRise of the biologics
Antibodies, RNA and gene therapy don’t necessarily compete with small molecule drugs – and they all rely on chemistry
-
BusinessDrug formula change infuriates French thyroid patients
Poor communication of changes to Merck KGaA’s levothyroxine has led to complaints of side effects
-
-
ResearchQuick test on pinprick of blood could help stop Ebola in its tracks
Portable Raspberry Pi-based device accurately detects viruses in micro droplet of whole blood
-
PodcastCinnarizine (stugeron)
Neil Withers relives a choppy (and messy) sea voyage to bring us the science of anti-seasickness drug cinnarizine
-
PodcastSodium dichromate
Discover the compound at the heart of a multi-million dollar legal case and an Oscar–winning role for Julia Roberts
-
NewsExplainer: What is cryo-electron microscopy
The science behind the 2017 Nobel prize in chemistry
-
BusinessAmgen partners to launch biosimilars in China
US biopharma and Chinese generics firm will co-develop medicines from Amgen’s pipeline focused on inflammation and oncology
-
FeatureThe long road to an HIV vaccine
A vaccine may not be available anytime soon, but its proponents are hard at work
-
OpinionAn opportunity ignored
Dismissing ideas that were ‘not invented here’ is like walking past a $100 bill
-
BusinessTeva sells off contraceptive device in $1.1bn deal
CooperSurgical to acquire Paragard as Teva seeks to offload assets
-
ResearchShop receipts may explain majority of BPA detected in people
Skin contact with dermal paper may be a much more important source of endocrine disruptor than previously thought